Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801

Synapse

Volumn 26, Issue 3, 1997, Pages 218-224

  Mele, Andrea ^a,b   Fontana, David ^a,c   Pert, Agu ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ROCHE BIOSCIENCE   (United States)

Author keywords

amphetamine; dopamine; microdialysis; MK 801; phencyclidine; striatum

Indexed keywords

AMPHETAMINE; DIZOCILPINE; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXIDOPAMINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CORPUS STRIATUM; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NEOSTRIATUM; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA;

EID: 0031004873     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199707)26:3<218::AID-SYN3>3.0.CO;2-A     Document Type: Article

References (23)

1. Carboni, E., Imperato, A., Perezzani, L., and DiChiara, G. (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience, 28:653-666.
2. Carlsson, M., and Carlsson, A. (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural. Transm. 75:221-226.
3. Chapman, C.D., Gazzara, R.A., and Howard, S.G. (1990) Effects of phencyclidine on extracellular levels of dopamine, dihydroxyphenyl-acetic acid and homovanillic acid in conscious and anesthetized rats. Neuropharmacology, 29:319-325.
4. Fessier, R.G., Sturgeon, R.D., and Meltzer, H.Y. Phencyclidine-induced ipsilateral rotation in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra. Life Sci., 24:1281-1288.
5. Finnegan, K.T., Kanner, M.I., and Meltzer, H.Y. (1976) Phencyclidine-induced rotational behavior in rats with nigrostriatal lesions and its modulation by dopaminergic and cholinergic agents. Pharmacol. Biochem. Behav., 5:651-660.
6. Fontana, D.J., Post, R.M., and Pert, G. (1997) Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res., 629:31-39.
7. Halpain, S., Girault, J.-A., and Greengard, D. (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature, 343:369-372.
8. 3H-PCP binding. Pharmacol. Biochem. Behav., 22:731-735.
9. Kanner, M., Finnegan, K., and Meltzer, H.Y. (1975) Dopaminergic effects of phencyclidine in rats with nigrostriatal lesions. Psychopharmacol. Commun. 1:393-401.
10. Kashihara, K., Hamamura, T., Okumura, K., and Otsuki, S. (1990) Effect of MK-801 on endogenous dopamine release in vivo. Brain Res., 528:80-82.
11. Martin, G.E., and Papp, N.L. (1984) Blockade of MK-801 induced ipsiversive turning in 6-OHDA lesioned rats by alpha-1-adrenoceptor antagonists. Pharmacol. Biochem. Behav., 20:893-897.
12. Maurice, T., Vignon, J., Kamenka, J.-M., and Chichepartiche, R. (1991) Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo. J. Neurochem., 56:553-559.
13. Maurice, T., Roman, F.J., Pascaud, X., Kamenka, J.-M., and Junien, J.-L. (1992) Regional differences in the effect of N-[1-(2-benzodiazepine (b) thiophenyl) cyclohexyl] piperidine (BTCP) on extracellular dopamine levels: An in vivo microdialysis study. Neurosci. Lett., 138:63-66.
14. McCullough, L.D., and Salamone, J.D. (1992) Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res., 577:1-9.
15. Morelli, M., and Di Chiara, G. (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur. J. Pharmacol., 182:611-612.
16. Rothman, R.B., Reid, A.A., Mann, J.A., Jacobson, A.E., and Rice, K.C. (1989) The psychomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: Evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites. Mol. Pharmacol., 36:887-895.
17. Smith, A.D., and Balam, J.P. (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci., 13:259-265.
18. Tiedtke, P.I., Bischoff, C., and Schmidt, W.J. (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J. Neural Transm., 81:173-182.
19. Ungerstedt, U. (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. [Suppl.] 367:49-67.
20. Weihmuller, F.B., O'Dell, S.J., Cole, B.N., and Marshall, J.F. (1991) MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: An in vivo microdialysis study. Brain Res., 549:230-235.
21. Whitton, P.S., Biggs, C.S., Pearce, B.R. and Fowler, L.J. (1992) Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett., 142:5-8.
22. Wong, E.H.F., and Kemp, J.A. (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu. Rev. Pharmacol. Toxicol., 31:401-425.
23. Zetterstrom, T., Sharp, T., and Ungerstedt, U. (1986) Further evaluation of the mechanism by which amphetamine reduces striatal dopamine metabolism: An in vivo brain dialysis study. Eur. J. Pharmacol., 132:1-9.